CalciMedica is trading 5.6% lower at $1.60; no clear company-specific catalyst for the September 29 move was identified.

  • The decline follows a 4.0% loss at the September 28 close of $1.68.
  • CalciMedica’s investor-relations releases list September 8 as its latest press release.
  • Broader indexes are mixed with modest moves, and available evidence does not establish a market-wide cause.